We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effect of Acorus tatarinowii extract on hyperprolactinemia in rats.
- Authors
Hong Zheng; Fu-tao Zhang; Hong-mei Tang; Jin-zhao Zhao; Xian-jun Meng; Wan-jing Sun
- Abstract
Purpose: To determine the mechanism underlying the anti-hyperprolactinemia effect of Acorus tatarinowii extract (ATE) in rats. Methods: Rats were divided into six groups (n =10 each group), viz, healthy control, untreated hyperprolactinemic rats, hyperprolactinemic rats treated with bromocriptine (0.6 mg/kg), and hyperprolactinemic rats treated with ATE (3.2, 6.4, or 12.8 g/kg). After 30 days, the hypothalamic protein levels of dopamine D2 receptor, protein kinase A (PKA), and cyclic adenosine monophosphate (cAMP) were determined. Results: Dopamine D2 receptor levels were lower in untreated hyperprolactinemic rats than in healthy control (p < 0.01), but this decrease was attenuated by ATE (p < 0.05). Elevated PKA levels in untreated hyperprolactinemic rats (0.78 ± 0.03µg/mL, p < 0.01) were decreased by ATE (3.2 g/kg, 0.51 ± 0.02 µg/mL, p < 0.05; 6.4 g/kg, 0.39 ± 0.03 µg/mL, p < 0.01; 12.8 g/kg, 0.24 ± 0.04 µg/mL, p < 0.01). Similarly, elevated cAMP levels in hyperprolactinemic rats (3.1 ± 0.3 ng/mL) were lowered by ATE (3.2 g/kg, 2.2 ± 0.4 ng/mL, p < 0.05; 6.4 g/kg, 1.8 ± 0.3 ng/mL, p < 0.01; 12.8 g/kg, 1.4 ± 0.3 ng/mL, p < 0.01). Conclusion: ATE anti-hyperprolactinemia activity is mediated by dopamine D2 receptor signaling via cAMP/PKA pathway.
- Subjects
SPRAGUE Dawley rats; RATS; CYCLIC adenylic acid; DOPAMINE receptors; PROTEIN kinases
- Publication
Tropical Journal of Pharmaceutical Research, 2019, Vol 18, Issue 11, p2411
- ISSN
1596-5996
- Publication type
Article
- DOI
10.4314/tjpr.v18i11.26